Fujifilm seeks perfect fit as tailored peptides progress for prostate cancer
This article was originally published in Scrip
Executive Summary
As part of a strategic effort to build up its fledgling pharmaceuticals business, Fujifilm is planning to take the concept of tailored therapy to new Savile Row-like levels of fit.